As technological advances in next-generation diagnostics are spurring growth and innovation in health care, rapid, precise diagnosis is regcognized by many as essential for personalized medicine.
This meeting offers a broad view of the changing landscape of diagnostics and brings together many key players in the clinical diagnostics field.
The meeting is officially called: The Next Generation Dx Summit: Enabling Point-of-Care Diagnostics, Cancer Molecular Markers to Guide Therapy, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Molecular Profiling of Circulating Tumor Cells
It will be held from August 20 to 22 at the Hyatt Regency on Capitol Hill, Washington, DC.
Speakers will hail from industry, government, and leading academic institutions.
Concurrent programs will be offered as follows:
August 21 to 22:
Molecular Diagnostics for Infectious Disease
[removed]Molecular Profiling of Circulating Tumor Cells[/removed] (new this year)
Commercialization of Molecular Diagnostics
The meeting will showcase improvements in technology research and development with an emphasis on applications in the clinic and commercialization.
Click here for more information:
[Source: Cambridge Healthtech Institute]